Scrolling View

Listed View

Subscribe

MedIntelliBlog →
proven intelligence solutions

WeirdMedical^TM...
anomalies for strange times

MedIntelliBase: 3-week free trial - pick your topic

First annual Translational Regenerative Medicine Forum in Winston-Salem
News-Medical.Net, 2010-02-21
"The Regenerative Medicine Foundation today announced the first annual Translational Regenerative Medicine Forum to be held April 6-8, 2010 at the Benton Convention Center in Winston-Salem..."

Personalized Medicine Experts Say the Future of Healthcare is Here Today
Medical Letter on the CDC & FDA, 2010-02-14
"The treatment of illness has traditionally been based on the law of averages - what works best for the largest number of patients. As a result, billions of dollars are spent every year..."

Morningside and Can Fite BioPharma to Establish a Joint Venture to Develop and Commercialize Can-Fite’s CF102 Drug for the Treatment of Liver Diseases
Can-Fite BioPharma, 2010-02-06
"Can-Fite BioPharma Ltd (TASE:CFBI), a biopharmaceutical company, announced today the signing of a memorandum of understanding (MOU), with the Hong Kong based Morningside Asia Venture..."

U.S. Venture Capital Investment Finishes Year Strong with Flurry of Deals in 4Q
PRNewswire, 2010-02-06
"An overall bad year ended on a high note as venture deal activity increased in the fourth quarter of 2009. Venture investors put $6.3 billion to work in 743 deals in..."

If you have any questions or comments about this service we welcome your feedback.

Best regards -

Jordan & Vicky

---

Jordan Zornes
    -- Editor & Senior Analyst | Phone 1-425.894.4147 | jpz@medintellibase.com

Vicky Hunsicker Sanko
    -- Senior Editor, President & CEO | Office Phone – 1-425-869-8724 – Mobile Phone – 1 -206-669-3053| vhs@medintellibase.com

---

*, ® - "The Next Phase" and "MedIntelliBase" are registered trademarks of The Next Phase Consultancy, Inc.